Patients predict own cognitive decline

| | Health Imaging | Neuroimaging

As neuroimaging research continues to push the boundaries on early Alzheimer’s disease detection, some experts are finding the patient knows best.

Subjective cognitive decline—or a person’s own impression of subtle changes in cognition—is an idea gaining traction, according to a New York Times report. Researchers at Brigham and Women’s Hospital in Boston have even found that patients who are concerned about their memory are more likely to have increased levels of amyloid in their brains.

Read more at the link below:

Looking for Early Signs of Dementia? Ask the Patient

Related Content

Altered brain structure may play a role in eating disorders, MRI data suggest
Experts update AUC for amyloid, tau PET imaging for first time in more than a decade
Infamous kidnapping survivor shares brain scan findings detailing the impact of her trauma
New algorithm is twice as accurate at predicting stroke timing compared to the standard of care
How gaming addiction affects brain activity, according to new MRI data
How opioid use disorder affects brain size and function

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.